Millie
your market intelligence analyst
Search Results
1,595 results
Your search is now limited to «Breast Cancer» expert search.
ClinicalTrials.gov 07/18/2019 07:49
The benefits of physical exercise programs in breast cancer survivors is well known.
More from ClinicalTrials.gov:
PubMed News (NIH) 07/18/2019
Contributors : María E Calleja-Cervantes ; J Gómez-Miragaya ; E González-Suárez Series Type : Methylation profiling by genome tiling array Organism : Homo sapiens. Illumina Infinium MethylationEPIC Beadchip was used to obtain DNA methylation profiles across 850000 CpGsites in nine different breast cancer PDX models.
More from PubMed News (NIH):
Bisphosphonates and primary breast cancer risk: an updated systematic review and meta-analysis involving 963,995 women.
More from International Journal of COPD:
Targeted Oncology 07/17/2019 16:00
CASE 1 A postmenopausal 55-year-old African American woman was given a diagnosis of breast cancer 2 years ago, after discovering a lump in her right breast.
More from Targeted Oncology:
Woman accidentally breaks 'cancer-free' bell in excitement over defeat of breast cancer.
More from Mail on Sunday (United Kingdom):
FoxNews (United States) 07/17/2019 13:43
Texas breast cancer survivor breaks hospitals 'end-of-treatment bell' while celebrating.
More from FoxNews (United States):
FDLI SmartBrief 07/17/2019 12:20
Health Canada has approved Puma Biotechnology's Nerlynx, or neratinib, as an extended ancillary treatment for women with early-stage breast cancer who have completed prior adjuvant therapy with Roche's Herceptin, or trastuzumab.
More from FDLI SmartBrief:
Breast Cancer News 07/17/2019 11:39
Trilaciclib , a treatment that protects the bone marrow from the damaging effects of chemotherapy, significantly extends the lives of women with metastatic triple-negative breast cancer receiving a chemotherapy regimen of gemcitabine and carboplatin , G1 Therapeutics announced.
More from Breast Cancer News:
HER2 (human epidermal growth factor receptor 2) is a protein that is associated with some particularly aggressive forms of breast cancer. The presence of high concentrations of this protein seems to lead to the growth of tumors, so inactivating HER2 may help to stop the spread of certain strains of cancer in the body. An […]
More from Medgadget - Internet Journal of Emerging Medical Technologies:
Technology Org 07/17/2019 09:51
The number of women diagnosed with breast cancer in China has increased in recent years,(2) with an estimated 368,000 new cases of breast cancer and approximately 98,000 related deaths in 2018.3 Breast cancer is now the most frequently diagnosed cancer ...
More from Technology Org:
ecancer news 07/17/2019 09:47
These findings help us understand how Slug functions in normal breast tissue and how it may function in breast cancer," said breast cancer researcher Charlotte Kuperwasser at Tufts University School of Medicine.
More from ecancer news:
FiercePharmaManufacturing 07/17/2019 09:09
Novartis’ Kisqali, trailing Lilly’s Verzenio, nabs limited NICE backing in breast cancer.
More from FiercePharmaManufacturing:
Cleveland Clinic researcher Dr. Vincent Tuohy has been developing a method to vaccinate women against contracting breast cancer, focused specifically on triple negative breast cancer (TNBC), the most lethal form of the disease.
More from Healthcare Sales & Marketing Network:
Business Wire 07/17/2019 08:00
A clinical study demonstrated the effectiveness of QuantX at helping radiologists interpret cancerous and non-cancerous breast lesions, leading to a 39% reduction in missed breast cancers without a reduction in specificity, as well as a 20% overall diagnostic improvement.
More from Business Wire:
pharmaphorum 07/17/2019 05:42
At the time, Baroness Delyth Morgan, chief executive of charities Breast Cancer Care and Breast Cancer Now, said the decision was “deeply disappointing” and denied a “vital additional option 2 to thousands of breast cancer patients.
More from pharmaphorum:
Medindia.com 07/17/2019 01:35
Results were validated in a separate cohort of 38 additional breast cancer patients to create a benchmark that predicts if a breast cancer patient will likely relapse within a handful of years.
More from Medindia.com:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications